MedTrace Logo

A Food Effect Study of TS-142 in Healthy Subjects

NCT05707897 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-02-28

No results posted yet for this study

Summary

This is a study to assess the food effect of TS-142 preliminary market formulation tablet in healthy subjects

Conditions

  • Effect of Food

Interventions

DRUG

TS-142 10 mg

Single-dose of 10 mg of TS-142

Sponsors & Collaborators

  • Taisho Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Taisho Director · Taisho Pharmaceutical Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2023-03-20
Completion
2023-03-20

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05707897 on ClinicalTrials.gov